COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 2445: Articles 24441-24450  | Next

A High-throughput Anti-SARS-CoV-2 IgG Testing Platform for COVID-19
Du, J., Chu, E., Zhang, D., Lu, C. M., Zhang, A., Sha, M. Y.
10.1101/2020.07.23.20160804 — Posted: 2020-07-27 Discussion: Onsite
Assessing the quality of nontraditional N95 filtering face-piece respirators available during the COVID-19 pandemic
Plana, D., Tian, E., Cramer, A. K., Yang, H., Carmack, M. M., Sinha, M. S., Bourgeois, F. T., Yu, S. H., Masse, P., Boyer, J., Kim, M., Mo, J., LeBoeuf, N. R., Li, J., Sorger, P. K.
10.1101/2020.07.25.20161968 — Posted: 2020-07-27
Mathematical modelling based study and prediction of COVID-19 epidemic dissemination under the impact of lockdown in India
Tiwari, V., Bisht, N., Deyal, N.
10.1101/2020.07.25.20161885 — Posted: 2020-07-27
Covid-19 automated diagnosis and risk assessment through Metabolomics and Machine-Learning
Delafiori, J., Navarro, L. C., Siciliano, R. F., de Melo, G. C., Busanello, E. N. B., Nicolau, J. C., Sales, G. M., de Oliveira, A. N., Val, F. F. A., de Oliveira, D. N., Eguti, A., dos Santos, L. A., Dalcoquio, T. F., Bertolin, A. J., Alonso, J. C. C., Abreu-Netto, R. L., Salsoso, R., Baia-da-Silva, D., Sampaio, V. S., Judice, C. C., Costa, F. M. T., Duran, N., Perroud, M. W., Sabino, E. C., Lacerda, M. V. G., Reis, L. O., Favaro, W. J., Monteiro, W. M., Rocha, A. R., Catharino, R. R.
10.1101/2020.07.24.20161828 — Posted: 2020-07-27 Discussion: Onsite
Using social contact data to predict and compare the impact of social distancing policies with implications for school re-opening
Brooks-Pollock, E., Read, J. M., McLean, A. R., Keeling, M. J., Danon, L.
10.1101/2020.07.25.20156471 — Posted: 2020-07-27
Trends in Angiotensin Receptor Blocker Use Among those at Risk for COVID-19 Morbidity and Mortality in the United States
Perez, A., Speth, R., Saavedra, J.
10.1101/2020.07.24.20161851 — Posted: 2020-07-27
Power Law in COVID-19 Cases in China
Ahundjanov, B. B., Akhundjanov, S. B., Okhunjanov, B. B.
10.1101/2020.07.25.20161984 — Posted: 2020-07-27
Evaluating SARS-CoV-2 spike and nucleocapsid proteins as targets for IgG antibody detection in severe and mild COVID-19 cases using a Luminex bead-based assay
Marien, J., Michiels, J., Heyndrickx, L., Kerkhof, K., Foque, N., Widdowson, M.-A., Desombere, I., Jansens, H., Van Esbroeck, M., Arien, K. K.
10.1101/2020.07.25.20161943 — Posted: 2020-07-27
Impact of COronaVirus Disease -2019 (COVID-19) pandemic on Haemodialysis care delivery pattern in Karnataka, India- a cross-sectional, questionnaire based survey.
Y J, A., Conjeevaram, A., Prabhu A, R., Doshetty, M., Srinivasa, S., Moger, V.
10.1101/2020.07.25.20151225 — Posted: 2020-07-27
Safety and Efficacy Concerns of Lopinavir/Ritonavir in COVID-19 Affected Patients: A Retrospective Series
Lepage, M.-A., Rozza, N., Kremer, R., Grunbaum, A.
10.1101/2020.07.23.20153932 — Posted: 2020-07-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).